Vinh Thanh Tran
Papers
1
Total Citations
2
H-Index
1
About
Vinh Thanh Tran is a researcher at the forefront of drug delivery innovation, specializing in the development of orally ingestible robotic pill technologies for biopharmaceuticals. His most cited work, a 2023 study presented at a major endocrinology conference, demonstrates a proof-of-concept for a once-daily follicle-stimulating hormone (FSH) biosimilar delivered via the RT-112 robotic pill. This research addresses a critical patient preference for oral over injectable administration, potentially transforming the management of fertility treatments and hormone therapies. With 2 citations to date, this early-stage work signals growing interest in non-invasive delivery systems. Tran’s contributions are particularly notable for bridging patient-centered design with advanced bioengineering, offering a tangible path toward reducing injection-related burdens. As an employee of Rani Therapeutics, he is part of a team pioneering this disruptive platform, which could extend beyond FSH to other biologics. His work underscores a commitment to improving therapeutic adherence and quality of life, positioning him as a key figure in the evolution of smart pill technologies for chronic and acute care.
Research Focus
Key Achievements
Top Papers
- 1